INDIANAPOLIS--(BUSINESS WIRE)--Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, expects the evolution from cardiac SPECT to cardiac PET imaging will be greatly accelerated with the recent changes in reimbursement from the Centers for Medicare & Medicaid Services (CMS) set for 2010.
